Wakefield Asset Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,133
Closed -$1.46M 212
2025
Q4
$1.46M Buy
18,133
+42
+0.2% +$3.52K 0.4% 74
2025
Q3
$1.77M Buy
18,091
+24
+0.1% +$1.93K 0.48% 64
2025
Q2
$1.26M Buy
+18,067
New +$1.03M 0.35% 89
2024
Q1
Sell
-5,937
Closed -$770K 147
2023
Q4
$770K Buy
5,937
+589
+11% +$81.2K 0.29% 113
2023
Q3
$872K Sell
5,348
-218
-4% -$38.3K 0.39% 67
2023
Q2
$1.02M Sell
5,566
-2,077
-27% -$299K 0.41% 69
2023
Q1
$1.02M Sell
7,643
-2,414
-24% -$284K 0.42% 61
2022
Q4
$798K Sell
10,057
-2,291
-19% -$161K 0.34% 88
2022
Q3
$748K Sell
12,348
-2,330
-16% -$151K 0.34% 79
2022
Q2
$805K Sell
14,678
-48
-0.3% -$2.78K 0.34% 76
2022
Q1
$1.11M Buy
14,726
+65
+0.4% +$4.44K 0.4% 74
2021
Q4
$1.09M Buy
+14,661
New +$869K 0.38% 75

Other funds holding ACLS

Wakefield Asset Management's ACLS Position: Q1 2026 in Review

Wakefield Asset Management sold out of Axcelis (ACLS) in Q1 2026, closing a stake of 18,133 shares — an estimated $1.46M sold.

Wakefield Asset Management first reported a position in ACLS in Q4 2021 and held it in 12 quarters. The position peaked at $1.77M in Q3 2025. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Wakefield Asset Management reported no remaining Axcelis position as of Q1 2026 after selling out during the quarter.
  • Wakefield Asset Management sold 18,133 Axcelis shares in Q1 2026, an estimated $1.46M.
  • Wakefield Asset Management first reported a position in Axcelis in Q4 2021 and held it in 12 quarters.
  • Wakefield Asset Management's Axcelis position peaked at $1.77M in Q3 2025.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Wakefield Asset Management's 13F filing for Q1 2026, filed 12 May 2026.